Biohit Oyj (BIOBV) - Product Pipeline Analysis, 2014 Update

Date: December 10, 2014
Pages: 31
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: BA095BB6D4DEN
Leaflet:

Download PDF Leaflet

Biohit Oyj (BIOBV) - Product Pipeline Analysis, 2014 Update
Summary

Biohit Oyj (Biohit) is a biotechnology company. The company develops manufactures and markets diagnostic tests and analysis system. Its products include acetaldehyde binding products, diagnostic tests, monoclonal antibodies, instruments and pipettes. Biohit develops and manufactures monoclonal antibodies for research use and use as raw materials for diagnostic industry. The company also provides laboratory equipment, such as microplate instruments and automates, as well as liquid handling products to support Biohit ELISA tests. It offers tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, and the ColonView examination for the early detection of fecal occult intestinal bleeding. Biohit is headquartered in Helsinki, Finland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biohit Oyj
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Biohit Oyj Company Snapshot
Biohit Oyj Company Overview
Key Information
Biohit Oyj Pipeline Products and Clinical Trials Overview
Biohit Oyj – Pipeline Analysis Overview
Key Facts
Biohit Oyj - Major Products and Services
Biohit Oyj Pipeline Products by Development Stage
Biohit Oyj Pipeline Products Overview
Gastrin-17 ELISA
Gastrin-17 ELISA Product Overview
Helicobacter Pylori IgG ELISA
Helicobacter Pylori IgG ELISA Product Overview
Pepsinogen I ELISA
Pepsinogen I ELISA Product Overview
Pepsinogen II ELISA
Pepsinogen II ELISA Product Overview
Biohit Oyj - Key Competitors
Biohit Oyj - Key Employees
Biohit Oyj - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Biohit Oyj, Recent Developments
Aug 29, 2014: Changes to Biohit Oyj’s management
Aug 21, 2014: Biohit group Announces interim report Q2/2014
Jun 26, 2014: Biohit appoints Quick Test distributor in Germany
Aug 26, 2013: Changes to Biohit Oyj’s management
Aug 08, 2013: Biohit Announces Q2 2013 Results
Aug 01, 2013: Biohit launches a new quick test - diagnosis of celiac disease possible from fingertip blood sample
May 16, 2013: Biohit Signs Distribution Agreement With Hefei Medicine To Market GastroPanel In China
Apr 25, 2013: Biohit Announces Q1 2013 Results
Feb 27, 2013: Biohit Announces 2012 Results
Oct 25, 2012: Biohit Announces Q3 2012 Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Biohit Oyj, Key Facts
Biohit Oyj Pipeline Products and Clinical Trials Overview
Biohit Oyj Pipeline Products by Equipment Type
Biohit Oyj Pipeline Products by Indication
Biohit Oyj, Key Facts
Biohit Oyj, Major Products and Services
Biohit Oyj Number of Pipeline Products by Development Stage
Biohit Oyj Pipeline Products Summary by Development Stage
Gastrin-17 ELISA - Product Status
Gastrin-17 ELISA - Product Description
Helicobacter Pylori IgG ELISA - Product Status
Helicobacter Pylori IgG ELISA - Product Description
Pepsinogen I ELISA - Product Status
Pepsinogen I ELISA - Product Description
Pepsinogen II ELISA - Product Status
Pepsinogen II ELISA - Product Description
Biohit Oyj, Key Employees
Biohit Oyj, Subsidiaries

LIST OF FIGURES

Biohit Oyj Pipeline Products by Equipment Type
Biohit Oyj Pipeline Products by Development Stage
Skip to top


Ask Your Question

Biohit Oyj (BIOBV) - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: